Media Center

Earlier this year, Oswald became the first broker to offer The Galleri Test: A new blood test for cancer screening. Employers can add this service to their existing employee benefits portfolio.

We are always searching for innovative ways to enable our clients and their employees to avoid risk so they can focus on enjoying life. By offering the Galleri test as an employee benefit, we have the potential to help our clients save lives and reduce health care spending, which leads to healthier employees and stronger employers. Read the full press release HERE.

Listen to our Q&A from June 21 to learn more about the test and how it works from and employer standpoint.

Presented by

• Tom Sigman, Strategic Solutions Leader, Oswald Companies
• Mark Russo, Director, Employee Partnerships, GRAIL

Webinar On-Demand | Passcode: Galleri1!

This webcast is presented by Oswald Companies, a Unison Risk Advisors Company and Grail, a health care company whose mission is to detect cancer early when it can be cured.

For more information, contact us here.

Note: This communication is for informational purposes only, and is not intended to offer legal, tax, or client-specific risk management advice. Information in this communication is not meant to describe specific coverages that may be advisable or available to you or your company, or to interpret specific coverages that may already be in place. General insurance descriptions in this communication do not include complete insurance policy definitions, terms, and/or conditions, and should not be relied on for coverage interpretation. Actual insurance policies must always be consulted for full coverage details and analysis. View our privacy notice.